Literature DB >> 6112358

Safety of coronary arterial prostacyclin infusion.

R J Hall, H A Dewar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6112358     DOI： 10.1016/s0140-6736(81)91648-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Coronary artery calibre after direct intra-arterial infusion of epoprostenol (prostacyclin).

Authors:  J Wilson; N P Silverton; M W Baig; E J Perrins; D R Smith; J A Davies; C R Prentice
Journal:  Br Heart J       Date:  1988-11

Review 2.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 3.  Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

Review 4.  Prostaglandins and the cardiovascular system.

Authors:  J R Vane
Journal:  Br Heart J       Date:  1983-05

Review 5.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

6.  Prostacyclin.

Authors:  J R Vane
Journal:  J R Soc Med       Date:  1983-04       Impact factor: 18.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.